Velan Inc. Reports Fiscal 2026 Fourth-Quarter and Year-End Results
Velan’s full-year turnaround is overshadowed by a pending takeover; the fourth-quarter loss and tariff uncertainty leave little to cheer about.
The most recent release (May 14, 2026) details Velan’s fiscal 2026 fourth‑quarter and full‑year results.
- For the full year, continuing operations swung to net income of $15.3 million ($0.71 per share) from a loss of $67.2 million a year earlier. Including a large gain on the sale of French subsidiaries, total net income was $73.9 million.
- The fourth quarter, however, showed a net loss from continuing operations of $3.9 million (versus a $16.1 million loss in Q4 2025), with sales up only 2.1 % and a lower gross margin.
- Backlog grew 3.1 % to $283.3 million, and bookings of $295.0 million were modestly ahead of the prior year.
- Liquidity is strong: cash of $53.4 million and total available liquidity of $102.6 million.
- The news reiterates that the controlling shareholder (Velan Holding) is selling a 72.1 % stake to Birch Hill Equity Partners for C$13.10 per share (gross proceeds ~C$204 million). The transaction is expected to close in the first half of 2026; dividends remain suspended until then.
- Earlier news items: Q2 FY2026 (Oct 2025) showed weak results and declining bookings; Q3 FY2026 (Jan 2026) brought a return to net income and a 32 % jump in bookings, alongside the announcement of the Birch Hill deal. A major nuclear valve order (>C$20 million) for Pickering was booked in October 2025.
The fiscal‑year earnings release is largely a confirmation of the turnaround story that was already visible in the Q3 results. The full‑year profit is a marked improvement, but the Q4 loss highlights ongoing margin pressure and mixed operating momentum.
The market’s reaction was muted; the stock barely moved on the day (closing at $15.74). The Birch Hill takeover, announced in January and still pending, remains the dominant narrative. That deal values the whole company at only C$13.10 per share, well below the current trading price, and the premium for minority holders is non‑existent. Because the buyout is at a discount, the stock is trading more on speculative hopes that the closing will unlock value or that a higher competing bid might emerge—not on the quarterly fundamentals.
No genuinely new, market‑moving information emerged from this release; the earnings were in line with the trajectory implied by previous quarters. The rating remains routine neutral.
Velan Inc. is a global manufacturer of industrial valves, serving nuclear power generation (CANDU reactors, emergency cooling injection valves), oil & gas, and other demanding industries. Its flagship recent contract is the >C$20 million order from Ontario Power Generation to supply valves for the Pickering Nuclear Generating Station refurbishment—a project that reinforces its long‑standing relationship with the Canadian nuclear sector. The company operates in North America, Europe, and the Middle East, including a new joint venture in Saudi Arabia. Velan has a 75‑year history and was previously controlled by the Velan family through Velan Holding Co.